您现在位置： -医药产业 >> 研究报告 >> English reports >> English reports >> 浏览医药行业研究报告

Market report of Antipsychotic drugs

讯：

Market report of Antipsychotic drugs  (2007 edition)

Publisher: Orient Health Electronic Commercial(Beijing)co.,Ltd
Published:  January 2007
Format:  Adobe PDF
Price:  US$ 2,400
Contact: Mr. Bian chenghua   Ms. Wu huifang
Tel.: 86-10-68012929-2116/2101             Fax:  86-10-68052525
E-mail: bianch@healthoo.com   wuhf@healthoo.com   

1 Summary
2 Classfication of antipsychotic drugs and overview of market
  2.1 Epidemic trend of psychiatric diseases and case rate
  2.2 Classfication of antipsychotic drugs
  2.3 General situation about the development of antipsychotic drugs
3 Market statistic of antipsychotic drugs
  3.1 Maket scales of antipsychotic drugs from 2002 to 2006
  3.2 Maket shares of different antipsychotic drugs from 2002 to 2006
  3.3 Maket shares of antipsychotic drugs with different adminstration ways
4 Analysis on key breeds
  4.1 Risperidone
      4.1.1 Main clinical applications and the backgroud of R&D
      4.1.2 Market scales, growth rates and market shares of different brands from

2002 to 2006
  4.2 Olanzapine
      4.2.1 Main clinical applications and the backgroud of R&D
      4.2.2 Market scales, growth rates and market shares of different brands from

2002 to 2006
  4.3 Quetiapine
      4.3.1 Main clinical applications and the backgroud of R&D
      4.3.2 Market scales, growth rates and market shares of different brands from

2002 to 2006
  4.4 Aripiprazole
      4.4.1 Main clinical applications and the backgroud of R&D
      4.4.2 Market scales, growth rates and market shares of different brands from

2002 to 2006
  4.5 Others
5 Market shares of different brands
   5.1 Regional distribution of brands
   5.2 Market shares of different brands in key cities
      5.2.1 Beijing
      5.2.2 Shanghai
      5.2.3 Guangzhou
      5.2.4 Others
6 R&D information
  6.1 List of domestic marketed products and import procucts
  6.2 List of enterprises which are applying the registertion of Sulpiride
  6.3 The trial drugs in the whole world

Tables and figures
Table 1 Antipsychotic drugs marketed in global market
Table 2 Maket scales and growth trend of antipsychotic drugs from 2002 to 2006
Table 3 Sales rank of different antipsychotic drugs from 2002 to 2006
Table 4 Sales values of different brands for Risperidone from 2002 to 2006
Table 5 Sales values of different brands for Olanzapine from 2002 to 2006
Table 6 Sales shares of different brands for Olanzapine from 2002 to 2006
Table 7 Sales values of different brands for Quetiapine from 2002 to 2006
Table 8 Sales shares of different brands for Quetiapine from 2002 to 2006
Table 9 Sales values of different brands for Aripiprazole from 2005 to 2006
Table 10 Market scales and growth of different brands from 2002 to 2006
Table 11 Market shares of different brands in Beijing in 2005
Table 12 Market shares of different brands in Beijing in 2006
Table 13 Market shares of different brands in Shanghai in 2005
Table 14 Market shares of different brands in Shanghai in 2006
Table 15 Market shares of different brands in Guangzhou in 2005
Table 16 Market shares of different brands in Guangzhou in 2006
Table 17 Market shares of different brands in other cities in 2005
Table 18 Market shares of different brands in other cities in 2006
Table 19 List of antipsychotic drugs produced by domestic enterprises
Table 20 List of imported antipsychotic drugs
Table 21 The trial drugs in the whole world

Figure 1 Growth trend of antipsychotic drugs from 2002 to 2006
Figure 2 Sales values of different antipsychotic drugs from 2002 to 2006
Figure 4 Sales values of typical and non-typical antipsychotic drugs from 2002 to 2006
Figure 5 Sales shares of typical and non-typical antipsychotic drugs from 2002 to 2006
Figure 6 Sales comparison of top 5 antipsychotic drugs from 2002 to 2006
Figure 7 Sales values of antipsychotic drugs with different adminstration ways from 2002 to 2006
Figure 8 Sales shares of antipsychotic drugs with different adminstration ways from 2002 to 2006
Figure 9 Growth trend of Risperidone from 2002 to 2006
Figure 10 Growth trend of Olanzapine from 2002 to 2006
Figure 11 Market shares of different enterprises for Olanzapine from 2002 to 2006
Figure 12 Growth trend of Quetiapine from 2002 to 2006
Figure 13 Market shares of different enterprises for Quetiapine from 2002 to 2006
Figure 14 Market shares of different brands from 2002 to 2006
Figure 15 Regional distribution of top 5 brands in key cities in 2005
Figure 16 Regional distribution of top 5 brands in key cities in 2006
Figure 17 Market shares of different brands in Beijing, Shanghai, Guangzhou in 2005
Figure 18 Market shares of different brands in Beijing, Shanghai, Guangzhou in 2006